FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4253259085> ?p ?o ?g. }

• W4253259085 endingPage "1720" @default.
• W4253259085 startingPage "1715" @default.
• W4253259085 abstract "Despite use of thromboprophylaxis, elective hip-replacement surgery carries a high risk of venous thromboembolic complications. We aimed to assess the ability of the pentasaccharide fondaparinux, the first of a new class of synthetic antithrombotic agents, to further reduce this risk.In a double-blind study, we randomly assigned 2309 consecutive patients aged 18 years or older who were undergoing elective hip-replacement surgery to once daily, subcutaneous injections of either 2.5 mg fondaparinux, starting postoperatively, or 40 mg enoxaparin, starting preoperatively. The primary efficacy outcome was venous thromboembolism up to day 11, defined as deep-vein thrombosis detected by mandatory bilateral venography, documented symptomatic deep-vein thrombosis, or documented symptomatic pulmonary embolism. The main safety outcomes were bleeding and death. The duration of follow-up was 6 weeks. Analysis was per protocol.We assessed the primary efficacy outcome in 1827 (79%) of 2309 patients. By day 11, venous thromboembolisms were recorded in 37 (4%) of 908 patients assigned to fondaparinux and in 85 (9%) of 919 assigned to enoxaparin (difference -5.2% [95% CI -8.1 to -2.7], p<0.0001). The relative reduction in risk was 55.9% (95% CI 33.1-72.8). The two groups did not differ in frequency of death or clinically relevant bleeding.Drugs that act through specific inhibition of factor Xa, such as fondaparinux, could be more effective than low molecular weight heparins in prevention of venous thromboembolism in patients undergoing hip-replacement surgery." @default.
• W4253259085 created "2022-05-12" @default.
• W4253259085 creator A5009969822 @default.
• W4253259085 creator A5086575517 @default.
• W4253259085 creator A5088333216 @default.
• W4253259085 creator A5090494524 @default.
• W4253259085 date "2002-05-01" @default.
• W4253259085 modified "2023-10-05" @default.
• W4253259085 title "Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison" @default.
• W4253259085 cites W1972497303 @default.
• W4253259085 cites W1984529493 @default.
• W4253259085 cites W1987745038 @default.
• W4253259085 cites W2000130043 @default.
• W4253259085 cites W2010599049 @default.
• W4253259085 cites W2048032060 @default.
• W4253259085 cites W2054169479 @default.
• W4253259085 cites W2070822165 @default.
• W4253259085 cites W2071155706 @default.
• W4253259085 cites W2077207459 @default.
• W4253259085 cites W2118803000 @default.
• W4253259085 cites W2133048039 @default.
• W4253259085 cites W2138478053 @default.
• W4253259085 cites W2158381418 @default.
• W4253259085 cites W2166945512 @default.
• W4253259085 cites W2181822657 @default.
• W4253259085 cites W2321004276 @default.
• W4253259085 cites W2325632732 @default.
• W4253259085 cites W4211038839 @default.
• W4253259085 cites W4232051294 @default.
• W4253259085 cites W4323283680 @default.
• W4253259085 cites W45169395 @default.
• W4253259085 cites W70359381 @default.
• W4253259085 cites W74544974 @default.
• W4253259085 doi "https://doi.org/10.1016/s0140-6736(02)08652-x" @default.
• W4253259085 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12049858" @default.
• W4253259085 hasPublicationYear "2002" @default.
• W4253259085 type Work @default.
• W4253259085 citedByCount "323" @default.
• W4253259085 countsByYear W42532590852012 @default.
• W4253259085 countsByYear W42532590852013 @default.
• W4253259085 countsByYear W42532590852014 @default.
• W4253259085 countsByYear W42532590852015 @default.
• W4253259085 countsByYear W42532590852016 @default.
• W4253259085 countsByYear W42532590852017 @default.
• W4253259085 countsByYear W42532590852018 @default.
• W4253259085 countsByYear W42532590852019 @default.
• W4253259085 countsByYear W42532590852020 @default.
• W4253259085 countsByYear W42532590852021 @default.
• W4253259085 countsByYear W42532590852022 @default.
• W4253259085 countsByYear W42532590852023 @default.
• W4253259085 crossrefType "journal-article" @default.
• W4253259085 hasAuthorship W4253259085A5009969822 @default.
• W4253259085 hasAuthorship W4253259085A5086575517 @default.
• W4253259085 hasAuthorship W4253259085A5088333216 @default.
• W4253259085 hasAuthorship W4253259085A5090494524 @default.
• W4253259085 hasConcept C126322002 @default.
• W4253259085 hasConcept C141071460 @default.
• W4253259085 hasConcept C168563851 @default.
• W4253259085 hasConcept C2776265017 @default.
• W4253259085 hasConcept C2776348710 @default.
• W4253259085 hasConcept C2776541429 @default.
• W4253259085 hasConcept C2776877702 @default.
• W4253259085 hasConcept C2776884760 @default.
• W4253259085 hasConcept C2777015399 @default.
• W4253259085 hasConcept C2778269268 @default.
• W4253259085 hasConcept C2778336525 @default.
• W4253259085 hasConcept C2778825682 @default.
• W4253259085 hasConcept C2778885795 @default.
• W4253259085 hasConcept C2778959117 @default.
• W4253259085 hasConcept C2780011451 @default.
• W4253259085 hasConcept C2780868729 @default.
• W4253259085 hasConcept C2991741193 @default.
• W4253259085 hasConcept C42219234 @default.
• W4253259085 hasConcept C71924100 @default.
• W4253259085 hasConceptScore W4253259085C126322002 @default.
• W4253259085 hasConceptScore W4253259085C141071460 @default.
• W4253259085 hasConceptScore W4253259085C168563851 @default.
• W4253259085 hasConceptScore W4253259085C2776265017 @default.
• W4253259085 hasConceptScore W4253259085C2776348710 @default.
• W4253259085 hasConceptScore W4253259085C2776541429 @default.
• W4253259085 hasConceptScore W4253259085C2776877702 @default.
• W4253259085 hasConceptScore W4253259085C2776884760 @default.
• W4253259085 hasConceptScore W4253259085C2777015399 @default.
• W4253259085 hasConceptScore W4253259085C2778269268 @default.
• W4253259085 hasConceptScore W4253259085C2778336525 @default.
• W4253259085 hasConceptScore W4253259085C2778825682 @default.
• W4253259085 hasConceptScore W4253259085C2778885795 @default.
• W4253259085 hasConceptScore W4253259085C2778959117 @default.
• W4253259085 hasConceptScore W4253259085C2780011451 @default.
• W4253259085 hasConceptScore W4253259085C2780868729 @default.
• W4253259085 hasConceptScore W4253259085C2991741193 @default.
• W4253259085 hasConceptScore W4253259085C42219234 @default.
• W4253259085 hasConceptScore W4253259085C71924100 @default.
• W4253259085 hasIssue "9319" @default.
• W4253259085 hasLocation W42532590851 @default.
• W4253259085 hasLocation W42532590852 @default.
• W4253259085 hasOpenAccess W4253259085 @default.
• W4253259085 hasPrimaryLocation W42532590851 @default.

• next